Botanix Completes Enrolment of BTX 1204 Atopic Dermatitis Study
• Successfully completed enrolment of the BTX 1204 atopic dermatitis patient study
• Botanix remains on track to release Phase 1b results in 2Q CY2018
• Supports the ability to accelerate multiple clinical programs by leveraging previous clinical data
• Botanix is also well advanced with preparations for Phase 2 study for BTX 1503
Ann: Enrolment of BTX 1204 Atopic Dermatitis Study Completed, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.0¢ | $1.594M | 9.684M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 3839900 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 913601 | 19 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |